Topal, E. Et Al. 2006. The effect of moxonidine on endothelial dysfunction in metabolic syndrome.. American journal of cardiovascular drugs : drugs, devices, and other interventions , vol.6 , 343-8.

Topal, E., Cikim, A. S., Cikim, K., Temel, I., & Ozdemir, R., (2006). The effect of moxonidine on endothelial dysfunction in metabolic syndrome.. American journal of cardiovascular drugs : drugs, devices, and other interventions , vol.6, 343-8.

Topal, Ergun Et Al. "The effect of moxonidine on endothelial dysfunction in metabolic syndrome.," American journal of cardiovascular drugs : drugs, devices, and other interventions , vol.6, 343-8, 2006

Topal, Ergun Et Al. "The effect of moxonidine on endothelial dysfunction in metabolic syndrome.." American journal of cardiovascular drugs : drugs, devices, and other interventions , vol.6, pp.343-8, 2006

Topal, E. Et Al. (2006) . "The effect of moxonidine on endothelial dysfunction in metabolic syndrome.." American journal of cardiovascular drugs : drugs, devices, and other interventions , vol.6, pp.343-8.

@article{article, author={Ergun Topal Et Al. }, title={The effect of moxonidine on endothelial dysfunction in metabolic syndrome.}, journal={American journal of cardiovascular drugs : drugs, devices, and other interventions}, year=2006, pages={343-8} }